Cornelis D de Kroon
Overview
Explore the profile of Cornelis D de Kroon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
514
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brink G, Groeneweg J, Sickinghe A, Nijman H, van Lonkhuijzen L, Lok C, et al.
J Ovarian Res
. 2025 Feb;
18(1):37.
PMID: 39987174
Background: As current literature does not provide sufficient data to support clear guidelines in patients with a rare adult-type granulosa cell tumor, we aim to investigate: (1) whether additional staging...
2.
Brink G, Hami N, Mertens S, Nijman H, van Lonkhuijzen L, Roes E, et al.
Mol Cancer Ther
. 2024 Nov;
PMID: 39600124
In patients with the rare adult-type granulosa cell tumors (aGCT), surgery is the primary treatment for both primary and recurrent disease. In cases of inoperable disease, systematic therapy is administered,...
3.
Ciggaar I, de Muynck L, de Geus-Oei L, van Velden F, de Kroon C, Arias-Bouda L, et al.
Nucl Med Biol
. 2024 Sep;
138-139:108952.
PMID: 39326323
Purpose: The selection for either primary or interval cytoreductive surgery (CRS) in patients with epithelial ovarian cancer (EOC) is currently based on imaging techniques like computed tomography (CT), [F]fluorodeoxyglucose-positron emission...
4.
Ruytenberg T, Ciggaar I, Peters I, Noortman W, Dibbets-Schneider P, de Muynck L, et al.
Mol Imaging Biol
. 2024 May;
26(4):577-584.
PMID: 38775919
Purpose: To describe the pharmacokinetic properties of the [F]fluoro-polyethylene glycol(PEG)-folate radiotracer in PET/CT imaging of patients with advanced stage epithelial ovarian cancer (EOC). Procedures: In five patients with advanced EOC...
5.
Zelisse H, de Ridder S, van Gent M, Mom C, Wisman G, Roes E, et al.
Biopreserv Biobank
. 2024 Apr;
22(6):568-577.
PMID: 38682281
Biobanks play a crucial role in fundamental and translational research by storing valuable biomaterials and data for future analyses. However, the design of their information technology (IT) infrastructures is often...
6.
Ebben K, de Kroon C, Schmeink C, van der Hel O, van Vegchel T, Moncada-Torres A, et al.
Learn Health Syst
. 2023 Oct;
7(4):e10384.
PMID: 37860062
Introduction: Clinical practice guidelines (hereafter 'guidelines') are crucial in providing evidence-based recommendations for physicians and multidisciplinary teams to make informed decisions regarding diagnostics and treatment in various diseases, including cancer....
7.
Gao Y, Liu C, Li H, Xiong X, Li G, In t Veld S, et al.
Protein Cell
. 2023 Mar;
14(6):579-590.
PMID: 36905391
Platelets are reprogrammed by cancer via a process called education, which favors cancer development. The transcriptional profile of tumor-educated platelets (TEPs) is skewed and therefore practicable for cancer detection. This...
8.
Zelisse H, van Gent M, de Ridder S, van der Aa M, Van Altena A, Bart J, et al.
Gynecol Obstet Invest
. 2022 Nov;
87(6):389-397.
PMID: 36450222
Objectives: Ovarian cancer has the worst overall survival rate of all gynecologic malignancies. For the majority of patients, the 5-year overall survival rate of less than 50% has hardly improved...
9.
In t Veld S, Arkani M, Post E, Antunes-Ferreira M, DAmbrosi S, Vessies D, et al.
Cancer Cell
. 2022 Sep;
40(9):999-1009.e6.
PMID: 36055228
Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets are involved in cancer progression and are considered a promising biosource for...
10.
Luijten M, Van Weelden W, de Kroon C, Pijnenborg J, van Gent M
Ned Tijdschr Geneeskd
. 2022 Feb;
165.
PMID: 35129891
Background: The incidence of endometrial carcinoma (EC) is rising worldwide due to an increased life expectancy and obesity. Approximately 2% of patients with EC is under the age of 45....